Chime Financial Achieves First GAAP Profit, Raises Guidance, and Authorizes $200M Share Buyback
summarizeSummary
Chime Financial reported its first GAAP profitable quarter as a public company, exceeding revenue guidance and raising its full-year outlook, alongside authorizing an additional $200 million share repurchase program.
check_boxKey Events
-
Achieves First GAAP Profitability
Chime Financial reported a net income of $53 million with an 8% net margin for Q1 2026, marking its first GAAP profitable quarter as a public company.
-
Strong Q1 Financial Performance
Revenue grew 25% year-over-year to $647 million, exceeding guidance, with Adjusted EBITDA reaching $119 million (18% margin). Active Members increased 19% year-over-year to 10.2 million.
-
Raises Full-Year Guidance
The company raised its full-year 2026 guidance, now expecting revenue between $2.66 billion and $2.69 billion (22-23% YoY growth) and Adjusted EBITDA between $416 million and $431 million.
-
Authorizes $200 Million Share Repurchase
The board approved an additional share repurchase authorization of up to $200 million of its Class A common stock, following the completion of a prior program. This represents a substantial capital return initiative.
auto_awesomeAnalysis
This 8-K filing marks a significant turning point for Chime Financial, as the company reported its first quarter of GAAP profitability as a public entity, a major milestone demonstrating the strength and resilience of its business model. The strong financial performance, including exceeding revenue guidance and robust member growth, is further bolstered by an optimistic outlook with raised full-year guidance. The board's approval of an additional $200 million share repurchase authorization signals strong management confidence in the company's financial health and future prospects, providing a substantial capital return to shareholders. Investors should view this as a strong positive signal, indicating improved financial stability and a commitment to shareholder value.
At the time of this filing, CHYM was trading at $22.00 on NASDAQ in the Finance sector, with a market capitalization of approximately $8.3B. The 52-week trading range was $16.17 to $44.94. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.